Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (50): 8072-8076.doi: 10.3969/j.issn.2095-4344.2015.50.007

Previous Articles     Next Articles

Osteogenic differentiation of adipose-derived stem cells and the effect of melatonin on the bio-viability of differentiated cells

Lu Tan1, Wei Na2, Zhang Chao1, Dong Yu-zhen1   

  1. 1Department of Orthopeadic Surgery, the First affiliated Hospital of Xinxiang Medical University, Weihui 453100, Henan Province, China; 2Second Department of Neurology, the Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan Province, China
  • Received:2015-10-16 Online:2015-12-03 Published:2015-12-03
  • About author:Lu Tan, Studying for doctorate, Attending physician, Department of Orthopeadic Surgery, the First affiliated Hospital of Xinxiang Medical University, Weihui 453100, Henan Province, China
  • Supported by:

    Stem Cells; Adipose Tissue; Cell Differentiation; Osteoblasts; Melatonin; Tissue Engineering
    Funding: the Scientific Development Plan of Xinxiang City in 2015, No. 15SF27

Abstract:

BACKGROUND: Studies have indicated that melatonin can promote the differentiation of adipose-derived stem cells into neurons, and the effect of melatonin on the osteoblasts form adipose-derived stem cells is rarely reported.
OBJECTIVE: To observe the osteogenic differentiation of adipose-derived stem cells and the effect of melatonin on the bio-viability of differentiated cells.
METHODS: (1) Adipose-derived stem cells were isolated and purified from the inguinal fat of Kunming mice by type I collagenase digestion and differential adhesion method, respectively. Immunohistochemical staining of CD44 was used as a quality control. (2) Osteogenic induction medium was added to induce osteogenic 
differentiation of passage 2 adipose-derived stem cells. Alkaline phosphatase staining and von Kossa method were combined to evaluate differentiation condition. (3) Melatonin at variable concentrations was added to treat mature osteocytes originated from adipose-derived stem cells and MTT was applied to determine their viability at 24 and 48 hours after culture respectively to find out optimal condition of melatonin treatment. (4) Melatonin at the optimal concentration was used to treat differentiated cells and detect alkaline phosphatase activity after 3 days and 6 days respectively.
RESULTS AND CONCLUSION: (1) After seeding for 48 hours, most cells were adherent, and after 4 days, the cells displayed multiple shapes and colonies of different sizes formed. After subculture, cell morphology homogenized as spindle shape. Cells positive for CD44 were brownish yellow, and localized mainly on the cell membrane. (2) Differentiated cells were positive for von Kossa staining and black sediments scattered in the extracellular matrix. Alkaline phosphatase expressed positively, and brown-black particles, appeared within cells. (3) Melatonin supplement improved the viability of differentiated cells; and 1, 10 and 100 μmol/L was observed as the optimal concentrations both at 24 and 48 hours. (4) The intracellular alkaline phosphatatse activity was increased with time in all the groups (P < 0.05). Compared with the blank group, the intracellular alkaline phosphatase activity in Melatonin groups (1, 10 and
100 μmol/L) had no changes at 3 days, but significantly increased at 6 days (P < 0.05). These findings indicate that melatonin can enhance the proliferation of osteocytes differentiated from adipose-derived stem cells, and improve the activity of intracellular alkaline phosphatase. 

 

CLC Number: